These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26375816)

  • 1. High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer.
    van den Broek E; Dijkstra MJ; Krijgsman O; Sie D; Haan JC; Traets JJ; van de Wiel MA; Nagtegaal ID; Punt CJ; Carvalho B; Ylstra B; Abeln S; Meijer GA; Fijneman RJ
    PLoS One; 2015; 10(9):e0138141. PubMed ID: 26375816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
    van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
    Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
    Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
    Hugen N; Simmer F; Mekenkamp LJ; Koopman M; van den Broek E; de Wilt JH; Punt CJ; Ylstra B; Meijer GA; Nagtegaal ID
    Oncotarget; 2015 Sep; 6(28):25715-25. PubMed ID: 26329972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
    Carethers JM; Jung BH
    Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
    Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
    Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.
    van den Broek E; van Lieshout S; Rausch C; Ylstra B; van de Wiel MA; Meijer GA; Fijneman RJA; Abeln S
    F1000Res; 2016; 5():2340. PubMed ID: 28713543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
    Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
    World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
    Martin ES; Tonon G; Sinha R; Xiao Y; Feng B; Kimmelman AC; Protopopov A; Ivanova E; Brennan C; Montgomery K; Kucherlapati R; Bailey G; Redston M; Chin L; DePinho RA
    Cancer Res; 2007 Nov; 67(22):10736-43. PubMed ID: 18006816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
    Dienstmann R; Salazar R; Tabernero J
    Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma.
    Kurashina K; Yamashita Y; Ueno T; Koinuma K; Ohashi J; Horie H; Miyakura Y; Hamada T; Haruta H; Hatanaka H; Soda M; Choi YL; Takada S; Yasuda Y; Nagai H; Mano H
    Cancer Sci; 2008 Sep; 99(9):1835-40. PubMed ID: 18564138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of key driver genes in colorectal cancer progression and metastasis.
    Huang D; Sun W; Zhou Y; Li P; Chen F; Chen H; Xia D; Xu E; Lai M; Wu Y; Zhang H
    Cancer Metastasis Rev; 2018 Mar; 37(1):173-187. PubMed ID: 29322354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.
    Peeters M; Oliner KS; Parker A; Siena S; Van Cutsem E; Huang J; Humblet Y; Van Laethem JL; André T; Wiezorek J; Reese D; Patterson SD
    Clin Cancer Res; 2013 Apr; 19(7):1902-12. PubMed ID: 23325582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
    Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.